A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphoma
This study aimed to identify key prognostic factors for Natural killer/T-cell lymphoma (NKTCL) in the context of L-asparaginase/pegaspargase-based therapy and to develop a simplified yet accurate prognostic model for risk stratification. Data from 854 NKTCL patients at the Sun Yat-sen University Cancer Center were divided into a training cohort (n = 598) and an internal validation cohort (n = 256). A further 222 patients from Sichuan Cancer Hospital & Institute were used to create an external validation cohort. Least absolute shrinkage and selection operator (LASSO) and Cox regression were used to identify independent risk factors for overall survival (OS). A nomogram (Nomogram-CA) was constructed and evaluated using the consistency index (C-index), calibration curves, time-dependent ROC (tdROC) and decision curve analysis (DCA). Kaplan-Meier survival curves were generated to show the difference in OS between groups. Age, CA stage, B symptoms and hemoglobin (Hb) level were all identified as independent risk factors for OS. Nomogram-CA was constructed based on multivariate analysis results. The DCA curves demonstrated that Nomogram-CA provided more net benefit to patients in the training, internal validation and external validation cohorts. Furthermore, analysis of the Kaplan-Meier survival curve revealed a significantly lower survival rate among patients identified as high-risk by Nomogram-CA when compared to those classified as low-risk (P < 0.05). Nomogram-CA constructed based on independent prognostic factors has better predictive ability compared to the traditional staging system, which can assist clinical doctors in evaluating patient prognosis.
Authors
- Jingjing Ge (ORCID: https://orcid.org/0000-0003-1475-0278)
- Zegeng Chen (ORCID: https://orcid.org/0000-0003-4755-6711)
- Huawei Weng (ORCID: https://orcid.org/0000-0001-8057-8790)
- Qunli Xiong (ORCID: https://orcid.org/0000-0001-8319-2834)
- Huangming Hong
- Zongyao Huang
- Zhao Wang (ORCID: https://orcid.org/0000-0002-3628-5699)
- Ying Tian (ORCID: https://orcid.org/0000-0003-3225-7962)
- Tongyu Lin (ORCID: https://orcid.org/0000-0002-8040-339X)
- Huageng Huang (ORCID: https://orcid.org/0000-0003-1188-6911)
- Le Yu (ORCID: https://orcid.org/0009-0009-1635-2602)
- He Huang
Institutions
- University of Electronic Science and Technology of China (CN)
- Sun Yat-sen University (CN)
- Sichuan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Annals of Hematology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1007/s00277-025-06667-6
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Sun Yat-sen University Cancer Center